U.S. markets close in 2 hours 12 minutes
  • S&P 500

    3,901.83
    +0.01 (+0.00%)
     
  • Dow 30

    31,584.09
    +48.58 (+0.15%)
     
  • Nasdaq

    13,510.61
    -78.21 (-0.58%)
     
  • Russell 2000

    2,250.83
    -24.49 (-1.08%)
     
  • Crude Oil

    60.63
    -0.01 (-0.02%)
     
  • Gold

    1,735.20
    +12.20 (+0.71%)
     
  • Silver

    26.92
    +0.24 (+0.89%)
     
  • EUR/USD

    1.2089
    +0.0029 (+0.24%)
     
  • 10-Yr Bond

    1.4210
    -0.0250 (-1.73%)
     
  • GBP/USD

    1.3975
    +0.0054 (+0.39%)
     
  • USD/JPY

    106.7310
    +0.0010 (+0.00%)
     
  • BTC-USD

    47,757.84
    -1,035.46 (-2.12%)
     
  • CMC Crypto 200

    956.75
    -29.90 (-3.03%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

Ryman Healthcare (NZSE:RYM) Shareholders Booked A 89% Gain In The Last Five Years

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

When we invest, we're generally looking for stocks that outperform the market average. And while active stock picking involves risks (and requires diversification) it can also provide excess returns. To wit, the Ryman Healthcare share price has climbed 89% in five years, easily topping the market return of 50% (ignoring dividends).

See our latest analysis for Ryman Healthcare

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

During five years of share price growth, Ryman Healthcare achieved compound earnings per share (EPS) growth of 1.6% per year. This EPS growth is slower than the share price growth of 14% per year, over the same period. This suggests that market participants hold the company in higher regard, these days. That's not necessarily surprising considering the five-year track record of earnings growth.

The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).

earnings-per-share-growth
earnings-per-share-growth

We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. In the case of Ryman Healthcare, it has a TSR of 107% for the last 5 years. That exceeds its share price return that we previously mentioned. This is largely a result of its dividend payments!

A Different Perspective

While the broader market gained around 7.7% in the last year, Ryman Healthcare shareholders lost 3.6% (even including dividends). Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Longer term investors wouldn't be so upset, since they would have made 16%, each year, over five years. It could be that the recent sell-off is an opportunity, so it may be worth checking the fundamental data for signs of a long term growth trend. It's always interesting to track share price performance over the longer term. But to understand Ryman Healthcare better, we need to consider many other factors. Like risks, for instance. Every company has them, and we've spotted 3 warning signs for Ryman Healthcare (of which 1 is significant!) you should know about.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on NZ exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.